← All trials
NCT05564052
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 21, 2022
- Primary completion
- Nov 1, 2027
- Completion date
- Jul 1, 2033
- First posted
- Oct 3, 2022
- Last posted
- Dec 2, 2022
- Enrollment
- 490
- Arms / groups
- 6 / —
- Source
- AACT · ctgov ingestion
Sponsors
- PharmacyclicsCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.